Laboratorios Farmaceuticos ROVI Cash Flow Reinvestment Rate
Laboratorios Farmaceuticos ROVI cash flow reinvestment rate. Laboratorios Farmaceuticos ROVI (ROVI) has a Cash Flow Reinvestment Rate of 0.24x as of September 2025, reinvesting €17.62 Million (capex €17.62 Million ) from operating cash flow of €73.37 Million. Explore ROVI debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Laboratorios Farmaceuticos ROVI (2006–2024)
Cash flow reinvestment rate of Laboratorios Farmaceuticos ROVI from 2006 to 2024. Historical reinvestment intensity for Laboratorios Farmaceuticos ROVI across 18 annual periods. Explore Laboratorios Farmaceuticos ROVI (ROVI) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Laboratorios Farmaceuticos ROVI Cash Flow Reinvestment Rate by Year (2006–2024)
Laboratorios Farmaceuticos ROVI cash flow reinvestment rate by year from 2006 to 2024. Year-by-year capital reinvestment analysis for Laboratorios Farmaceuticos ROVI. For the full cash flow conversion analysis, see Laboratorios Farmaceuticos ROVI cash conversion from operations.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.04x | €143.28 Million | €138.28 Million | €62.22 Million | ▲ +9.4% |
| 2023 | 0.95x | €107.22 Million | €113.25 Million | €55.19 Million | ▲ +107.2% |
| 2022 | 0.46x | €108.54 Million | €237.60 Million | €51.39 Million | ▼ -16.5% |
| 2021 | 0.55x | €81.78 Million | €149.44 Million | €40.94 Million | ▼ -67.7% |
| 2020 | 1.69x | €79.32 Million | €46.88 Million | €39.69 Million | ▼ -45.5% |
| 2018 | 3.11x | €26.51 Million | €8.53 Million | €26.46 Million | ▲ +174.9% |
| 2017 | 1.13x | €20.39 Million | €18.04 Million | €19.94 Million | ▲ +49.7% |
| 2016 | 0.76x | €34.37 Million | €45.53 Million | €18.08 Million | ▲ +10.6% |
| 2015 | 0.68x | €20.07 Million | €29.39 Million | €19.90 Million | ▼ -61.9% |
| 2014 | 1.79x | €41.26 Million | €23.00 Million | €25.05 Million | ▲ +46.4% |
| 2013 | 1.23x | €36.54 Million | €29.82 Million | €24.68 Million | ▲ +75.2% |
| 2012 | 0.70x | €13.72 Million | €19.61 Million | €13.72 Million | ▲ +6.2% |
| 2011 | 0.66x | €8.35 Million | €12.68 Million | €8.35 Million | ▲ +150.3% |
| 2010 | 0.26x | €5.58 Million | €21.19 Million | €5.58 Million | ▼ -15.2% |
| 2009 | 0.31x | €2.99 Million | €9.62 Million | €2.99 Million | ▼ -59.6% |
| 2008 | 0.77x | €9.74 Million | €12.66 Million | €9.74 Million | ▼ -92.5% |
| 2007 | 10.19x | €11.73 Million | €1.15 Million | €11.73 Million | ▲ +1846.2% |
| 2006 | 0.52x | €4.04 Million | €7.72 Million | €4.04 Million | — |